BCIQ Profiles

Company Profile Report

Hydroxychloroquine testing Hahn’s, FDA’s independence as countries, scientists negate use

FDA’s decisions on hydroxychloroquine and chloroquine for COVID-19 have become a test of FDA Commissioner Stephen Hahn’s independence from political pressure, with mounting evidence of the drugs’ lack of benefit and dangerous cardiac liability. The question is whether, or when, Hahn will reverse course to protect patients and risk

Read the full 499 word article

How to gain access

Continue reading with a
two-week free trial.